AKR1C3 is an important human enzyme that participates in the reduction of steroids and prostaglandins, which leads to proliferative signalling. In addition, this enzyme also participates in the biotransformation of xenobiotics, such as drugs and procarcinogens. AKR1C3 is involved in the development of both hormone-dependent and hormone-independent cancers and was recently demonstrated to confer cell resistance to anthracyclines. Because AKR1C3 is frequently upregulated in various cancers, this enzyme has been suggested as a therapeutic target for the treatment of these pathological conditions. In this study, nineteen isoquinoline alkaloids were examined for their ability to inhibit a recombinant AKR1C3 enzyme. As a result, stylopine was demonstrated to be the most potent inhibitor among the tested compounds and exhibited moderate selectivity towards AKR1C3. In the follow-up cellular studies, stylopine significantly inhibited the AKR1C3-mediated reduction of daunorubicin in intact cells without considerable cytotoxic effects. This inhibitor could therefore be used as a model AKR1C3 inhibitor in research or evaluated as a possible therapeutic anticancer drug. Furthermore, based on our results, stylopine can serve as a model compound for the design and future development of structurally related AKR1C3 inhibitors.

ADINACO Research Group Department of Pharmaceutical Botany and Ecology Faculty of Pharmacy in Hradec Kralove Charles University Prague Heyrovskeho 1203 500 05 Hradec Kralove Czech Republic

Department of Biochemical Sciences Faculty of Pharmacy in Hradec Kralove Charles University Prague Heyrovskeho 1203 500 05 Hradec Kralove Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc15008081

003      

CZ-PrNML

005      

20150401085755.0

007      

ta

008      

150306s2014 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.jsbmb.2014.04.005 $2 doi

035    __

$a (PubMed)24769118

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Skarydova, Lucie $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

245    10

$a Isoquinoline alkaloids as a novel type of AKR1C3 inhibitors / $c L. Skarydova, J. Hofman, J. Chlebek, J. Havrankova, K. Kosanova, A. Skarka, A. Hostalkova, T. Plucha, L. Cahlikova, V. Wsol,

520    9_

$a AKR1C3 is an important human enzyme that participates in the reduction of steroids and prostaglandins, which leads to proliferative signalling. In addition, this enzyme also participates in the biotransformation of xenobiotics, such as drugs and procarcinogens. AKR1C3 is involved in the development of both hormone-dependent and hormone-independent cancers and was recently demonstrated to confer cell resistance to anthracyclines. Because AKR1C3 is frequently upregulated in various cancers, this enzyme has been suggested as a therapeutic target for the treatment of these pathological conditions. In this study, nineteen isoquinoline alkaloids were examined for their ability to inhibit a recombinant AKR1C3 enzyme. As a result, stylopine was demonstrated to be the most potent inhibitor among the tested compounds and exhibited moderate selectivity towards AKR1C3. In the follow-up cellular studies, stylopine significantly inhibited the AKR1C3-mediated reduction of daunorubicin in intact cells without considerable cytotoxic effects. This inhibitor could therefore be used as a model AKR1C3 inhibitor in research or evaluated as a possible therapeutic anticancer drug. Furthermore, based on our results, stylopine can serve as a model compound for the design and future development of structurally related AKR1C3 inhibitors.

650    _2

$a 3-hydroxysteroid dehydrogenasy $x antagonisté a inhibitory $7 D015096

650    _2

$a berberinové alkaloidy $x farmakologie $7 D001600

650    _2

$a western blotting $7 D015153

650    _2

$a nádory prsu $x farmakoterapie $x enzymologie $x patologie $7 D001943

650    _2

$a proliferace buněk $7 D049109

650    _2

$a viabilita buněk $x účinky léků $7 D002470

650    _2

$a vysokoúčinná kapalinová chromatografie $7 D002851

650    _2

$a kolorektální nádory $x farmakoterapie $x enzymologie $x patologie $7 D015179

650    _2

$a inhibitory enzymů $x farmakologie $7 D004791

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a hydroxyprostaglandindehydrogenasy $x antagonisté a inhibitory $7 D006911

650    _2

$a testosteron $x metabolismus $7 D013739

650    _2

$a nádorové buňky kultivované $7 D014407

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Hofman, Jakub $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Chlebek, Jakub $u ADINACO Research Group, Department of Pharmaceutical Botany and Ecology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Havrankova, Jana $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Kosanova, Katerina $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Skarka, Adam $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Hostalkova, Anna $u ADINACO Research Group, Department of Pharmaceutical Botany and Ecology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Plucha, Tomas $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Cahlikova, Lucie $u ADINACO Research Group, Department of Pharmaceutical Botany and Ecology, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic.

700    1_

$a Wsol, Vladimir $u Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic. Electronic address: wsol@faf.cuni.cz.

773    0_

$w MED00004950 $t The Journal of steroid biochemistry and molecular biology $x 1879-1220 $g Roč. 143, č. - (2014), s. 250-8

856    41

$u https://pubmed.ncbi.nlm.nih.gov/24769118 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20150306 $b ABA008

991    __

$a 20150401090025 $b ABA008

999    __

$a ok $b bmc $g 1065354 $s 890881

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2014 $b 143 $c - $d 250-8 $i 1879-1220 $m Journal of steroid biochemistry and molecular biology $n J Steroid Biochem Mol Biol $x MED00004950

LZP    __

$a Pubmed-20150306